A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3761-3767

  Chang, Bey Dih ^a   Broude, Eugenia V ^a   Dokmanovic, Milos ^a   Zhu, Hongming ^a   Ruth, Adam ^a   Xuan, Yongzhi ^a   Kandel, Eugene S ^a   Lausch, Ekkehart ^a   Christov, Konstantin ^a   Roninson, Igor B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APHIDICOLIN; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PROTEIN P53; VINCRISTINE;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; SENESCENCE; TREATMENT OUTCOME;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL AGING; CELL DIVISION; DOXORUBICIN; FEMALE; FIBROSARCOMA; GAMMA RAYS; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHENOTYPE; PLOIDIES; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 17444388849     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11: 121-139, 1992.
2. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-968, 1993.
3. Hendry, J. H., and West, C. M. L. Apoptosis and mitotic cell death: their relative contributions to normal-tissue and rumor radiation response. Int. J. Radiat. Biol., 71: 709-719, 1997.
4. Tounekti, O., Pron, G., Belehradek, J., Jr., and Mir, L. M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res., 53: 5462-5469, 1993.
5. Lock, R. B., and Stribinskiene, L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res., 56: 4006-4012, 1996.
6. Torres, K., and Horwitz, S. B. Mechanisms of Taxol-induced cell death are concentration-dependent. Cancer Res., 58: 3620-3626, 1998.
7. Demarcq, C., Bunch, R. T., Creswell, D., and Eastman, A. The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Differ., 5: 983-993, 1994.
8. 2-M-associated cell death after γ-irradiation. Oncogene, 14: 2759-2766, 1997.
9. Waldman, T., Lengauer, C., Kinzler, K. W., and Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (Lond.), 381: 713-716, 1996.
10. 2 arrest after DNA damage. Science (Washington DC), 282: 1497-1501, 1998.
11. Kung, A. L., Zetterberg, A., Sherwood, S. W., and Schimke, R. T. Cytotoxic effects of cell cycle phase specific agents: results of cell cycle perturbation. Cancer Res., 50: 7307-7317, 1990.
12. Fornari, F. A. Jr., Jarvis, W, D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K. H., Mumaw, V. R., Lovings, E. T., Freeman, R. H., and Gewirtz, D. A. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorabicin. Cell Growth Differ., 5: 723-733, 1994.
13. Hayflick, L., and Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res., 37: 585-621, 1961.
14. Smith, J. R., and Pereira-Smith, O. M. Replicative senescence: implications for in vivo aging and tumor suppression. Science (Washington DC), 273: 63-67, 1996.
15. Duncan, E. L., and Reddel, R. R. Genetic changes associated with immortalization. Biochemistry, 62: 1263-1274, 1997.
16. Dimri, G. P., Xinhua, L., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubej, I., Pereira-Smith, O., Peacocke, M., and Campisi, J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
17. Chen, Q., and Ames, B. N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA, 91: 4130-4134, 1994.
18. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
19. INK4A enrichment and the premature senescence of normal fibroblasts. Oncogene, 16: 1113-1123, 1998.
20. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88: 593-602, 1997.
21. Weinberg, R. A. The cat and mouse games that genes, viruses and cells play. Cell, 88: 573-575, 1997.
22. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
23. Linke, S. P., Clarkin, K. C., and Wahl, G. M. p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res., 57: 1171-1179, 1997.
24. INK4 and telomerase in immortalization of human cells. Oncogene, 11: 971-976, 1995.
25. Shay, J. W. Telomerase in human development and cancer. J. Cell Physiol., 173: 266-270, 1997.
26. Pereira-Smith, O. M., and Smith, J. R. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl. Acad. Sci. USA, 55: 6042-6046, 1988.
27. Sugrue, M. M., Shin, D. Y., Lee, S. W., and Aaronson, S. A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA, 94: 9648-9653, 1997.
28. Xu, H-J., Zhou, Y., Ji, W., Perng, G-S., Kruzelock, R., Kong, C-T., Bast, R. C., Mills, G. B., Li, J., and Hu, S-X. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene, 15: 2589-2596, 1997.
29. INK4A. Oncogene, 15: 505-514, 1997.
30. CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ., 9: 139-146, 1998.
31. Wang, X., Wong, S. C., Pan, J., Tsao, S. W., Fung, K. H., Kwong, D. L., Sham, J. S., Nicholls, J. M. Evidence of cisplatin-induced senescent-like growth arrest in nasopharyngeal carcinoma cells. Cancer Res., 58: 5019-5022, 1998.
32. Chang, B-D., and Roninson, I. B. Inducible retroviral vectors regulated by lac represser in mammalian cells. Gene, 183: 137-142, 1996.
33. Perry, M. E., Rolfe, M., McIntyre, P., Commane, M., and Stark, G. R. Induction of gene amplification by 5-aza-2′-deoxycytidine. Mutat. Res., 276: 189-197, 1992.
34. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
35. Brown, R., Marshall, C. J., Pennie, S. G., and Hall, A. Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. EMBO J., 3: 1321-1326, 1984.
36. Li, W., Fan, J., Hochhauser, D., Banerjee, D., Zielinski, Z., Almasan, A., Yin, Y., Kelly, R., Wahl, G. M., and Bertino, J. R. Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. Proc. Natl. Acad. Sci. USA, 24: 10436-10440, 1995.
37. Pellegata, N. S., Antoniono, R. J., Redpath, J. L., and Stanbridge, E. J. DNA damage and p53-mediated cell cycle arrest; a reevaluation. Proc. Natl. Acad. Sci. USA, 93: 15209-15214, 1996.
38. Horan, P. K., and Slezak, S. E. Stable cell membrane labeling. Nature (Lond.), 340: 167-168, 1989.
39. Sherwood, S. W., Rush, D., Ellsworth, J. L., and Schimke, R. T. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc. Natl. Acad. Sci. USA, 85: 9086-9090, 1988.
40. Ueda, H., Takenawa, T., Millan, J. C., Gesell, M. S., and Brandes, D. The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer (Phila.), 15: 2203-2209, 1980.
41. Guilbaud, N. F., Gas, N., Dupont, M. A., and Valette, A. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J. Cell Physiol., 145: 162-172, 1990.
42. Miller, F. R., Soule, H. D., Tait, L., Pauley, R. J., Wolman, S. R., Dawson, P. J., and Heppner, G. H. Xenograft model of progressive human proliferative breast disease. J. Natl. Cancer Inst., 85: 1725-1732, 1993.
43. Moon, R. C., Mehta, R. G., and Rao, K. V. N. Retinoids and cancer in experimental animals. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, Biology, Chemistry, and Medicine, pp. 573-595. New York: Raven Press, 1994.
44. Holt, S. E., Aisner, D. L., Shay, J. W., and Wright, W. E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl. Acad. Sci. USA, 94: 10687-10692, 1997.
45. Vaziri, H., West, M. D., Allsopp, R. C., Davison, T. S., Wu, Y. S., Arrowsmith, C. H., Poirier, G. G., and Benchimol, S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J., 16: 6018-6033, 1997.
46. waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene, 1999, in press.
47. Speth, P. A., Linssen, P. C., Boezeman, J. B., Wessels, H. M., and Haanen, C. Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother. Pharmacol., 20: 305-310, 1987.
48. Debernardis, D., Sire, E. G., DeFeudis, P., Vikhanskaya, F., Valenti, M., Russo, P., Parodi, S., D'Incalci, M., and Broggini, M. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res., 57: 870-874, 1997.
49. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebbardt, M., Bressac, B. Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
50. Hosono, S., Lee, C. S., Chou, M. J., Yang, C. S., and Shih, C. H. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene, 6: 237-243 1991.
51. Kim, M. S., Li, S. L., Bertolami, C. N., Cherrick, H. M., and Park, N. H. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res., 13: 1405-1413, 1993.
52. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S. Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J., Jr., and Kohn, K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57: 4285-4300, 1997.
53. Rodrigues, N. R., Rowan, A., Smith, M. E. F., Kerr, I. B., Bodmer, W. F., Gannon, J. V., and Lane, D. P. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87: 7555-7559, 1990.
54. Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. The state of p53 and retinoblastoma genes in human cervical carcinoma cell line. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
55. Yaginuma, Y., and Westphal, H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res., 51: 6506-6509, 1991.